New scan spots hidden heart disease in gene carriers before symptoms start

NCT ID NCT07591038

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to see if a new radioactive dye can detect early signs of a heart condition called amyloidosis in people who carry a TTR gene mutation but have no heart failure symptoms. About 80 adults aged 30-80 will receive an injection of the dye and then have a PET/CT scan to look for amyloid buildup in the heart. The goal is to find disease earlier so treatment can begin sooner.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UT Southwestern Medical Center

    Dallas, Texas, 75248, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.